Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
Duan Zeng,1,* Shen He,1,* Shunying Yu,1 Guanjun Li,1 Changlin Ma,2 Yi Wen,2 Yifeng Shen,1 Yimin Yu,1 Huafang Li1,3 1Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Shanghai Jiading District M...
Guardado en:
Autores principales: | Zeng D, He S, Yu S, Li G, Ma C, Wen Y, Shen Y, Yu Y, Li H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1598414897794c9291fe436da16e2b38 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect
por: Song X, et al.
Publicado: (2021) -
Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
por: Blat Diana, et al.
Publicado: (2021) -
Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
por: Bhattacharjee S, et al.
Publicado: (2020) -
Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
por: L. K. Khokhlov, et al.
Publicado: (2019) -
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha MK, et al.
Publicado: (2017)